TYMS and colonic neoplasm: It has been recently reported that HDACi synergize with 5-FU in vitro and in vivo in colon cancer cell line models through HDACi-induced downregulation of the 5-FU target enzyme thymidylate synthase (TS), providing a mechanistic basis for the drug synergy [25,29].